Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 15/20 | 0.48 |
| ▸ | PIK3CB | P42338 | 6/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.47 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.47 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.42 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124320 | 0.89 | PIK3CB (0.51) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL16308154 | 0.89 | PIK3CB (0.41) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL16308161 | 0.89 | PIK3CA (0.50) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL17529135 | 0.88 | PIK3CA (0.47) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL16308169 | 0.86 | PIK3CB (0.41) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL16308168 | 0.86 | PIK3CB (0.41) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL10124714 | 0.85 | PIK3CB (0.41) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL10124715 | 0.85 | PIK3CB (0.41) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL16308260 | 0.84 | PIK3CB (0.49) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD | |
| SCHEMBL15029343 | 0.83 | PIK3CB (0.51) | PIK3CAPIK3CBPIK3CDPIK3R1NAPEPLD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8912180-B2 | Heterocyclic compound | ASTELLAS PHARMA INC. (JP) | 2014-12-16 | — | — | US | disclosed |